# Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets

> **NCT01744288** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 258 (actual)

## Conditions studied

- Inhibition on Platelet Aggregation

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel
- **DRUG:** ASA

## Key facts

- **NCT ID:** NCT01744288
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2014-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744288, "Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on Platelets". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01744288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*